Owlstone Medical
Owlstone Medical to Join EU-Funded EPHOR Consortium
The consortium aims to further elucidate the complex relationships between environment and disease by developing the concept of the ‘working-life exposome’, which takes into account all occupational and related non-occupational exposures (e.g. lifestyle) throughout the lifespan of an individual.
Owlstone Medical
Owlstone Medical Partners with Thermo Fisher Scientific
The collaboration seeks to advance the application of non-invasive breath sampling to address the challenges of the early detection of disease and the precision medicine delivery of healthcare through the discovery and validation of novel biomarkers
Owlstone Medical
Breath Biopsy Kits Launched by Owlstone Medical
3/28/18: Commercially available research kits extend access to Breath Biopsy technology for discovery of VOC biomarkers in early disease detection and precision medicine
Owlstone Medical
Owlstone Medical and Cancer Research UK (CRUK) Initiate Pan Cancer Clinical Trial to Evaluate Breath Biopsy for Early Detection of Disease
Owlstone Medical, (diagnostics company developing a breathalyzer for disease), today announced the initiation of the PAN Cancer...
Owlstone Medical
Owlstone Medical CEO and Breath Biopsy Pioneer Billy Boyle wins Royal Academy of Engineering’s Silver Medal
Billy Boyle, Founder and CEO of Owlstone Medical, (a diagnostics company developing a breathalyzer for disease), is...
Owlstone Medical
Owlstone Medical Establishes Scientific Advisory Board with Appointment of Professor Sir Bruce Ponder
Billy Boyle, co-founder and CEO at Owlstone Medical, commented: “With over four decades’ work in cancer research...
Owlstone Medical
Owlstone Medical and Mayo Clinic Collaborate to Develop Pre-Endoscopic Test to Improve Effectiveness of Colonoscopy
Pilot study demonstrates FAIMS technology is able to detect patients inadequately prepped prior to colonoscopy with 100%...
